Diagnostic exhalations

November 06, 2014

Paramedics respond to a 911 call to find an elderly patient who's having difficulty breathing. Anxious and disoriented, the patient has trouble remembering all the medications he's taking, and with his shortness of breath, speaking is difficult. Is he suffering from acute emphysema or heart failure? The symptoms look the same, but initiating the wrong treatment regimen will increase the patient's risk of severe complications.

Researchers from MIT's Research Laboratory of Electronics, working with physicians from Harvard Medical School and the Einstein Medical Center in Philadelphia, believe that repurposing a piece of medical equipment standard in all ambulances in the United States and Europe could help paramedics make this type of field diagnosis.

In the December issue of IEEE Transactions on Biomedical Engineering, they present a new algorithm that can, with high accuracy, determine whether a patient is suffering from emphysema or heart failure based on readings from a capnograph --a machine that measures the concentration of carbon dioxide in a patient's exhalations.

"This machine is ubiquitous," says George Verghese, the Henry Ellis Warren Professor of Electrical and Biomedical Engineering at MIT and one of the paper's coauthors. "It's actually in every emergency department and operating room. But the use that they've typically made of it is much more limited than what we were attempting here."

In the United States, capnography was first introduced in the 1980s, as a way to aid medical professionals inserting breathing tubes into the tracheas of sedated patients. If the tube were accidentally inserted into the esophagus -- which leads to the stomach, rather than the lungs -- the capnograph would measure no carbon dioxide concentrations at all.

In that context, a capnogram is easy to read. If the capnograph displays a regular wave pattern, with crests for exhalations and troughs for inhalations, the tube has been inserted properly. If the capnogram flatlines, it hasn't been.

Rich signal

But over time, physicians observed that the capnograms of patients with congestive heart failure and emphysema -- or chronic obstructive pulmonary disease, as it's known in the medical literature -- were subtly but consistently different both from each other and from those of healthy subjects.

One of those physicians, Baruch Krauss, an emergency-medicine specialist at Boston Children's Hospital and an associate professor at Harvard Medical School, thought that the capnographic signal could be a source of diagnostically useful information, particularly for paramedics. A blood test performed in a hospital lab can accurately distinguish emphysema and heart failure, but it takes about an hour from the time a sample is received -- too long for a patient who's distressed enough to call 911.

Krauss was aware that the Computational Physiology and Clinical Inference Group at RLE specialized in novel diagnostic applications of minimally invasive sensors, so he requested a meeting with the group's leaders, Verghese and assistant professor of electrical and biomedical engineering Thomas Heldt, who has since joined MIT's Institute of Medical Engineering and Science. "We didn't even know the word 'capnography' until Baruch set up a meeting with us and came and told us about it," Verghese says.

Verghese and Heldt recruited Rebecca Mieloszyk, a student in their group who had just begun her master's degree, to investigate the relationship between patients' capnograms and their ultimate diagnoses.

Mieloszyk's first task was to identify features of the capnographic signal that appeared to vary between populations. The crests of the waves in healthy subjects' capnograms seemed to plateau at a maximum concentration, for instance, while those in sick patients' didn't. Other obvious factors to consider were the duration of the exhalations and the intervals between them.

Once she had identified maybe a dozen such features, she wrote a machine-learning algorithm that would look for patterns in the features that seemed to correlate with patients' ultimate diagnoses. But that algorithm was somewhat unconventional.

Democratic decisions

Rather than training a single classifier on one set of data and then turning it loose on another set to see how it performed, she split the training data into 50 subsets. Each subset consisted of a random selection of about 70 percent of the data -- so there was significant overlap between subsets, but no two subsets were identical. Then she used those subsets to train 50 different classifiers. The algorithm's ultimate output was the result of a vote by the 50 classifiers.

Diagnostic techniques are generally assessed according to their true-positive rates -- the fraction of actual cases that they successfully diagnose -- and their false-positive rates -- the fraction of healthy subjects they classify as sick. These can be plotted against each other on a graph, with true-positive as the y-axis and false-positive as the x-axis.

The ideal diagnostic would yield a straight line across the top of the graph: Its true-positive rate is always 1, even when the false-positive rate is 0. The line produces a square with an area of 1, since its top stretches from (0,1) to (1,1). So a good diagnostic is one whose area under the curve is close to 1.

In their tests, the MIT researchers and their colleagues found that their algorithm for distinguishing healthy subjects from those with emphysema yielded an area under the curve of 0.98. The algorithm that distinguished emphysema patients from those with congestive heart failure checked in at 0.89.

"[That] is very good performance," Krauss says. "Now, when the ambulance system picks up an elderly person who's short of breath, a lot of times they can't determine whether they're short of breath from emphysema or heart failure, so they just take their best guess. So when we're talking about guesstimates, I think we really do pretty well."

To determine precisely how well, however, the researchers are currently conducting a double-blind experiment in which paramedics assess the conditions of patients while also taking capnograms, whose results are analyzed by the MIT researchers' algorithm. In other work, other members of Verghese's and Heldt's team are evaluating whether capnography can measure the severity of asthma attacks and the degree of sedation in patients undergoing medical procedures.

Written by Larry Hardesty, MIT News Office

Related links

Making sense of medical sensors


Sensing when the brain is under pressure


Massachusetts Institute of Technology

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.